Cross-border health evidence from Government, and medical experts
11 December 2014
Welsh Affairs Committee take evidence on impact of cross-border healthcare. The Under-Secretary of State for Public Health, and representatives from the NHS, explain what the Government and NHS England are doing to make cross-border health work more effectively.
- Parliament TV: Cross-border health arrangements between England and Wales
- Inquiry: Cross-border health arrangements between England and Wales
- Welsh Affairs Committee
Witnesses
Tuesday 16 December 2014, Committee Room 8, Palace of Westminster
At 9.30am
- Dr Alan Rees RCP, Vice President for Wales, Royal College of Physicians
- Dr Frank Joseph RCP, Acute Care Fellow, Royal College of Physicians
- Dr Stephen Kelly, Welsh Consultants Committee, British Medical Association Wales
- Dr Peter Horvarth-Howard, General Practitioners Committee, British Medical Association Wales
At 10.15am
- Andrew Wilson-Webb, Chief Executive, Rarer Cancers Foundation
- Emma Hughes, Development Officer for Wales, Genetic Alliance UK
At 11am
- Jane Ellison MP, Parliamentary Under Secretary of State, Department of Health
- Ben Dyson, Director of NHS Group, Department of Health
- Ian Dodge, National Director for Commissioning Strategy, NHS England
Focus of the session
The Committee hears from three panels of witnesses. During the first panel the Committee explores the challenges doctors face working in cross-border healthcare.
The second panel features representatives from Rarer Cancers Foundation and Genetic Alliance UK. The Committee asks about the effects of cross-border healthcare arrangements on patients with rarer conditions and specialised requirements.
In the third panel, the Committee hears from Jane Ellison MP, Parliamentary Under-Secretary of State for Public Health, and NHS England. The Committee asks them what the Government and NHS England are doing to make cross-border health arrangements between England and Wales work more effectively.